In today's interconnected world, infectious diseases pose an escalating threat, as demonstrated by the coronavirus pandemic ...
Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a clinical-grade antiviral ...
Despite variations by age group and influenza virus type, the 2023-2024 influenza vaccine was protective against outpatient illness in pediatric and adult patients.
The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Center for ...
Pharma giant Eli Lilly has launched a new anti-obesity and diabetes drug in India called Mounjaro. Image courtesy: Adobe Stock US pharma giant Eli Lilly has ventured into India with an anti-obesity ...
Four antiviral drugs are available for the prevention and treatment of influenza infections: oseltamivir, zanamivir, rimantadine and amantadine. Oseltamivir and zanamivir are neuraminidase ...
Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with weight management and activates hormone receptors.
(Image/Getty) US pharma major Eli Lilly on Thursday launched its global bestseller anti-obesity and diabetes drug Mounjaro (tirzepatide) in India. Priced at Rs 14,000 for a 2.5 mg monthly dose (Rs ...
Novo Nordisk’s oral semaglutide tablet, Rybelsus, launched in India in January 2022, has already captured nearly 65 per cent of the anti-obesity drugs market, which includes other weight-loss ...
Further research revealed that one of these drugs, DDL-920 – developed at UCLA, led to the complete recovery of movement control – something many stroke patients never regain.
This trial, which focused on anti-amyloid drugs, was set up in 2012 when the participants had either no symptoms or just mild cognitive symptoms. At this stage, they were within 15 years before to ...
Effective antiviral drugs are therefore critically important as short-term therapies in the event of outbreaks of a novel influenza virus to which a susceptible population has little, or no ...